Evaluation of the effectiveness of galvanic vestibular stimulation in the rehabilitation of Mielopatia associada ao HTLV-1

Not Applicable

Recruiting

• Conditions: HTLV I Associated Myelopathy; C10.586

• Registration Number: RBR-9y34g7s
• Lead Sponsor: niversidade Federal de Minas Gerais

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-12-27
• Last Update Posted: 23 January 2024
• Study Completion: 2026-12-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Control group: Composed of individuals with negative serology for HTLV-1 by the ELISA (Enzyme-linked-immunosorbent -assay) test; Group with HTLV-1 infection: Composed of former blood donors from Fundação Hemominas with seropositivity defined by the ELISA test and confirmed through WB (Western Blot) or molecular tests (Polymerase Chain Reaction - PCR); HAM group: individuals with sufficient clinical signs, according to the criteria proposed by the adapted WHO (GRASSI et al, 2011; CASTRO-COSTA, 2006), classified according to the adapted Expanded Functional Disability Scale (EDSS) and OSAME presenting classification from two on both scales.

Exclusion Criteria

Positive serology for human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), positive Venereal Disease Research Laboratory (VDRL) test; History of stroke and epilepsy ; Inability to remain in the examination position; Recurrent episodes of vertigo or history of previously diagnosed peripheral vestibulopathy; Patients with a pacemaker or any device that may undergo changes resulting from the use of EVG; Cognitive changes justified by some other pathology associated with Parkinson's disease; Individuals who are alienated and unable to answer for their own actions.

Study & Design

• Study Type: Intervention
• Study Design: Not specified